Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 126.03 USD -1.28% Market Closed
Market Cap: 7.2B USD
Have any thoughts about
Ascendis Pharma A/S?
Write Note

Ascendis Pharma A/S
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ascendis Pharma A/S
EPS (Diluted) Peer Comparison

Comparables:
GMAB
ZEAL
B
BAVA
F
FLUO
BIOPOR

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Ascendis Pharma A/S
NASDAQ:ASND
EPS (Diluted)
-€8
CAGR 3-Years
0%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
EPS (Diluted)
kr84
CAGR 3-Years
31%
CAGR 5-Years
35%
CAGR 10-Years
43%
Zealand Pharma A/S
CSE:ZEAL
EPS (Diluted)
-kr14
CAGR 3-Years
17%
CAGR 5-Years
1%
CAGR 10-Years
-22%
B
Bavarian Nordic A/S
CSE:BAVA
EPS (Diluted)
kr8
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
Fluoguide AS
STO:FLUO
EPS (Diluted)
-kr3
CAGR 3-Years
-22%
CAGR 5-Years
-217%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
EPS (Diluted)
kr0
CAGR 3-Years
46%
CAGR 5-Years
9%
CAGR 10-Years
1%

See Also

What is Ascendis Pharma A/S's EPS (Diluted)?
EPS (Diluted)
-8.5 EUR

Based on the financial report for Jun 30, 2024, Ascendis Pharma A/S's EPS (Diluted) amounts to -8.5 EUR.

What is Ascendis Pharma A/S's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-18%

Over the last year, the EPS (Diluted) growth was 21%.

Back to Top